JavaScript Required We're sorry, but this site doesn't work properly without JavaScript enabled. If you can't enable JavaScript please click here to view settings.

All India Institute of Medical Sciences, Nagpur
All India Institute of Medical Sciences, Nagpur

* Everyone is informed that if any person demands money in the name of providing any kind of job in AIIMS Nagpur, then immediately inform the AIIMS Administration on no.07103-295590 about that person* Despite this public notice, if any person gives money in the name of getting any kind of job in AIIMS Nagpur, then it will be his own responsibility* Online registration for OPD appointment from home through E-vaidya mobile app.*,*Message from Hon'ble Shri J.P. NADDA Ji about vigiliance Awareness Week. *Admission for Post-Doctoral Certificate Courses for session April - 2026. *Notice regarding Document Verification against CRE AIIMS advertisement No.171/2025 dated 07.01.2025 * Eligibility against CRE AIIMS advertisement No.171/2025 dated 07.01.2025*

 

 

 
  • Designation: Associate Professor
  • Qualification: MBBD, MD General Medicine, Fellow TMC Kolkata Consultant Clinical Haemato-Oncolcogy and Bone Marrow Transplant, DM Clinical Hematology CMC, Vellore
  • Email: vkhushoo@aiimsnagpur.edu.in 
       Areas of expertise
  • Benign and malignant Hematology including Bone marrow transplant

 
Membership & Training

  • ISHBT, ISBMT, BJH, ASCO

Publications

  • Kapoor J, Pramanik SK, Agrawal P, Khushoo V, Naim F, Mirgh SP, et al. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplant. 2020 Apr 14
  • Bhurani D, Kapoor J, Yadav N, Khushoo V, Agrawal N, Ahmed R, et al. Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients. Ann Hematol. 2021 Jun 1;100(6):1417–27.
  • Mehta DMP, Khushoo V. Is Old (Fludrabine/Busulfan/Cyclophosphamide/ rAntiThymocyteGlobulin) Conditioning Still Gold for Allogeneic Transplants in Transfusion Dependent Beta-Thalassemia of All Risk Categories in 21st Century? Indian J Hematol Blood Transfus. 2023 Apr 3:1-9. doi: 10.1007/s12288-023-01646-1. Epub ahead of print. PMID: 37362406; PMCID: PMC10068721
  • Mehta P, Yadav N, Folbs B, Kapoor J, Khushoo V, Agrawal N, et al. Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India. Indian J Hematol Blood Transfus [Internet]. 2021 Jul 3
  • Sharma A, Ahmed R, Agrawal N, Kapoor J, Sharma A, Khushoo V, et al. Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era. Indian J Hematol Blood Transfus. 2021 Apr 1;37(2):240–8.
  •